MeltArray™ Technology

MeltArray™ Technology

High-Multiplex PCR + Melting Curve 2D Coding Platform

Overview

MeltArray™ is a high-multiplex PCR platform designed to break the traditional multiplex ceiling of real-time PCR. By combining fluorophore channel coding with melting temperature (Tm) signature analysis, MeltArray enables dozens of targets to be detected in a single reaction tube using a standard real-time PCR instrument.

meltarray

Scientific Foundation

MeltArray™ expands traditional multiplex PCR capacity by encoding targets through distinct melting curve signatures rather than fluorescence channel limitation. The platform design enables broad pathogen coverage without increasing instrument complexity.

Key Features:

  • High-level multiplexing (dozens of targets per reaction)

  • Rapid turnaround time (typically <3 hours)

  • Single-tube detection workflow

  • Quantitative Ct and qualitative Tm dual-readout system

Core Technical Capabilities

  • Up to 72 targets per reaction (platform capacity)

  • Dozens of mutations detectable in a single tube

  • 2D coding: Fluorophore channel + melting temperature signature

  • Compatible with standard 4-channel real-time PCR systems

Analytical Performance

  • Limit of detection (LOD): 0.05%–0.5% mutant allele fraction (MAF)

  • Mutation enrichment: 23.5× to 59.4×

  • SNV discrimination with high melting curve resolution

  • Artifact suppression using UNG pretreatment

Workflow Efficiency

  • Total turnaround time: <5 hours

  • Hands-on time: ~20 minutes

  • >90 samples per 96-well run

  • Single-tube pretreatment + single-tube detection

Clinical & Operational Advantages

  • Designed for FFPE tumor DNA workflows

  • Eliminates formalin-induced sequencing artifacts

  • Enables rapid therapy selection decisions

  • Cost-effective alternative to NGS for hotspot panels

Reference: Q. Huang et al, Highly multiplex PCR assays by coupling the 5′-flap endonuclease activity of Taq DNA polymerase and molecular beacon reporters, Proc. Natl. Acad. Sci. U.S.A. 119 (9) e2110672119, (2022).